These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23233144)

  • 1. [Spanish family with spastic paraplegia and demyelinating polyneuropathy: a disease related with PLP1 null syndrome].
    Pardal-Fernandez JM
    Rev Neurol; 2012 Dec; 55(12):765. PubMed ID: 23233144
    [No Abstract]   [Full Text] [Related]  

  • 2. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene.
    Hudson LD
    J Child Neurol; 2003 Sep; 18(9):616-24. PubMed ID: 14572140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
    Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
    J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.
    Hobson GM; Garbern JY
    Semin Neurol; 2012 Feb; 32(1):62-7. PubMed ID: 22422208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
    Inoue K
    Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited white matter disorders: Hypomyelination (myelin disorders).
    Perrier S; Gauquelin L; Bernard G
    Handb Clin Neurol; 2024; 204():197-223. PubMed ID: 39322379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the PLP1 gene residue p. Gly198 as the molecular basis of Pelizeaus-Merzbacher phenotype.
    Hoffman-Zacharska D; Kmieć T; Poznański J; Jurek M; Bal J
    Brain Dev; 2013 Oct; 35(9):877-80. PubMed ID: 23245814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arena syndrome is caused by a missense mutation in PLP1.
    Stevenson RE; Tarpey P; May MM; Stratton MR; Schwartz CE
    Am J Med Genet A; 2009 May; 149A(5):1081. PubMed ID: 19396823
    [No Abstract]   [Full Text] [Related]  

  • 10. Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptoms.
    Muncke N; Wogatzky BS; Breuning M; Sistermans EA; Endris V; Ross M; Vetrie D; Catsman-Berrevoets CE; Rappold G
    J Med Genet; 2004 Dec; 41(12):e121. PubMed ID: 15591263
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pelizaeus-Merzbacher disease(PMD)/spastic paraplegia 2(SPG2)].
    Eto Y
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):536-7. PubMed ID: 11032015
    [No Abstract]   [Full Text] [Related]  

  • 12. A new polymorphism in the proteolipid protein (PLP1) gene and its use for carrier detection of PLP1 gene duplication in Pelizaeus-Merzbacher disease.
    Hobson G; Stabley D; Funanage V; Marks H
    Hum Mutat; 2001 Feb; 17(2):152. PubMed ID: 11180600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.
    Cailloux F; Gauthier-Barichard F; Mimault C; Isabelle V; Courtois V; Giraud G; Dastugue B; Boespflug-Tanguy O
    Eur J Hum Genet; 2000 Nov; 8(11):837-45. PubMed ID: 11093273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
    Lossos A; Elazar N; Lerer I; Schueler-Furman O; Fellig Y; Glick B; Zimmerman BE; Azulay H; Dotan S; Goldberg S; Gomori JM; Ponger P; Newman JP; Marreed H; Steck AJ; Schaeren-Wiemers N; Mor N; Harel M; Geiger T; Eshed-Eisenbach Y; Meiner V; Peles E
    Brain; 2015 Sep; 138(Pt 9):2521-36. PubMed ID: 26179919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabbit paralytic tremor phenotype--a plp1 gene mutation as a model of human Pelizaeus-Merzbacher disease.
    Sypecka J; Domańska-Janik K
    Acta Neurobiol Exp (Wars); 2005; 65(2):221-9. PubMed ID: 15960310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
    Woodward KJ
    Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2.
    Noetzli L; Sanz PG; Brodsky GL; Hinckley JD; Giugni JC; Giannaula RJ; Gonzalez-Alegre P; Di Paola J
    Gene; 2014 Jan; 533(1):447-50. PubMed ID: 24103481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial PLP1 deletion causing X-linked dominant spastic paraplegia type 2.
    Matsufuji M; Osaka H; Gotoh L; Shimbo H; Takashima S; Inoue K
    Pediatr Neurol; 2013 Dec; 49(6):477-81. PubMed ID: 24095575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of the pathogenic mechanism and potential treatment strategy for a female patient with spastic paraplegia derived from a single-nucleotide deletion in PLP1.
    Yamamoto-Shimojima K; Imaizumi T; Aoki Y; Inoue K; Kaname T; Okuno Y; Muramatsu H; Kato K; Yamamoto T
    J Hum Genet; 2019 Jul; 64(7):665-671. PubMed ID: 31004103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease.
    Fattal-Valevski A; DiMaio MS; Hisama FM; Hobson GM; Davis-Williams A; Garbern JY; Mahoney MJ; Kolodny EH; Pastores GM
    J Child Neurol; 2009 May; 24(5):618-24. PubMed ID: 19151366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.